4
Changes in Ownership
Summit Therapeutics Inc. Filed Acc 0000921895-21-001334
Chief Operating Officer bought 389,077 shares at $5.24 ($2,038,763)
From the SEC's structured data for this filing
Trades in this filing
Zanganeh Maky · Chief Operating Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-05-12 | Purchase : show line 1 in the form | +389,077 | $5.24 | $2,038,763 | 2,643,319 | I |
| Open-market purchases · 389,077 sh · avg $5.24 · $2,038,763 | ||||||
Loading xslF345X03/form412566zan_05142021.xml…